IRIS
PELUSO, ANNA LUCIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 472
NA - Nord America 187
EU - Europa 169
SA - Sud America 76
Continente sconosciuto - Info sul continente non disponibili 65
AF - Africa 4
OC - Oceania 1
Totale 974
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 157
SG - Singapore 155
IT - Italia 151
CN - Cina 110
KR - Corea 64
BR - Brasile 60
IL - Israele 60
VN - Vietnam 43
MX - Messico 20
HK - Hong Kong 19
AR - Argentina 8
DE - Germania 7
BD - Bangladesh 5
ID - Indonesia 5
CA - Canada 3
EC - Ecuador 3
PL - Polonia 3
RU - Federazione Russa 3
EG - Egitto 2
IN - India 2
JM - Giamaica 2
TT - Trinidad e Tobago 2
UA - Ucraina 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
IQ - Iraq 1
JP - Giappone 1
MA - Marocco 1
MQ - Martinica 1
NL - Olanda 1
PE - Perù 1
PK - Pakistan 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PY - Paraguay 1
SA - Arabia Saudita 1
SE - Svezia 1
TH - Thailandia 1
TR - Turchia 1
TW - Taiwan 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZA - Sudafrica 1
Totale 910
Salva come PNG Salva come JPEG
Città #
Singapore 77
Chicago 66
Pescara 64
Seoul 64
Rome 62
Tel Aviv 60
Beijing 20
Hong Kong 19
Mexico City 17
Ho Chi Minh City 13
San Jose 9
Hanoi 7
Milan 5
São Paulo 5
Brasília 3
Hangzhou 3
Naples 3
New York 3
Palermo 3
Santa Clara 3
Belo Horizonte 2
Buffalo 2
Bắc Ninh 2
Can Tho 2
Curitiba 2
Da Nang 2
Guayaquil 2
Haiphong 2
Los Angeles 2
Montreal 2
Mumbai 2
Nam Định 2
Orem 2
Osasco 2
Philadelphia 2
Recife 2
Ribeirão Preto 2
Salvador 2
Thái Nguyên 2
Warsaw 2
Ajman 1
Al Mansurah 1
Albuquerque 1
Allen 1
Americana 1
Barberton 1
Bari 1
Barra do Piraí 1
Biên Hòa 1
Blenheim 1
Brescia 1
Briatico 1
Brooklyn 1
Brumadinho 1
Campina Grande 1
Campinas 1
Cananéia 1
Canoas 1
Canoga Park 1
Cape Girardeau 1
Carapicuíba 1
Casablanca 1
Castanhal 1
Cedar Hill 1
Chesapeake 1
Cincinnati 1
Ciudad Evita 1
Ciudad Guayana 1
Clorinda 1
Cromwell 1
Crossville 1
Cuenca 1
Cusco 1
Dammam 1
Deutschnofen 1
Dhaka 1
Diamantino 1
Dokki 1
Dom Eliseu 1
Dundalk 1
Dębica 1
El Paso 1
Folsom 1
Formiga 1
Formosa 1
Freehold 1
Groblersdal 1
Guajeru 1
Hicksville 1
Hidrolândia 1
Hurt 1
Hòa Bình 1
Ibiúna 1
Itajaí 1
Jacksonville 1
Jaguaquara 1
Joinville 1
Karachi 1
Kingston 1
Kinston 1
Totale 606
Salva come PNG Salva come JPEG
Nome #
Risorse genetiche di organismi utili per il miglioramento di specie di interesse agrario e per un'agricoltura sostenibile 25
Caratterizzazione dei ceppi di Rhizobium spp. Simbionti di leguminose selvatiche e coltivate del climax mediterraneo 19
cKIT mutations frequency detected in patients with Acute Myeloid Leukemia (AML) characterized by Core Binding Factor (CBF) rearrangement 19
The A1059E mutation in Jak2 gene was detected in patients with Idiopathic Erithrocytosis secondary to Acute Lymphoblastic Leukemia 19
Characterization of Rhizobium spp.strains symbionts of wild and cultivated legumes of the Mediterranean climax 18
Increasing BCR-ABL expression levels and/or occurrence of ABL point mutations not always predict resistance to Imatinib Mesylate in BCR-ABL positive Acute Lymphoblastic Leukemia 18
Heat Shock Protein 90 (HSP90) regulates the expression of preferentially Expressed Antigen of Melanoma (PRAME) in cell lines derived from patients with Chronic Myeloid Leukemia 18
Evaluation of proteolytic, lipolytic and decarboxylase activity of extremely halophilic bacteria occurring in ripening of salt anchovies 18
Clinical outcome of Chronic Myeloid Leukemia (CML) patients with deletion and Insertion events (DI) in the Tyrosine Kinase Domain of Bcr-Abl 18
Highly Sensitive Detection of BCR-ABL Kinase Domain Mutations in CML patients by an Ultra-Deep Sequencing Approach 17
High-avidity cytotoxic lymphocytes specific for a new peotide derived from Preferentially expressed Antigen of Melanoma (PRAME) can target leukemia precursor cells 17
Reduced levels of SHP1 provides an additive serviva advantage to the PH- cells of CML patients and may account for resistance to IMA treatment 17
Clinical relevance in Chronic Myeloid Leukemia of deletion and insertion events in the tyrosine Kinase domain of BCR-ABL 17
Ligh chains expression of lymphoid infiltrate in fine-needle cytology of Hashimoto's Thyroiditis 17
Mesenchymal stem cell (MSC) derived from bone marrow (BM) of patients with Chronic Myelogenous Leukemia protect Ph+ leukemic cells from TKI induced apoptosis 17
Unravelling the mechanism of resistance to Imatinib Mesylate in Chronic Myeloid Leukemia: a proteomic approach 17
The Expression of shp-1 and SHP-2: A Novel Powerful Predictor of Major Molecular Response (MMR) Achievement in Chronic Myeloid Leukemia Gleevec-Treated Patients Enrolled into the TOPS Clinical Trial 17
Acute and Chronic Ph+ leukemias: differential leukemogenesis pathways translate into different clinical needs 17
Clonal evolution in a case of hepatosplenic T cell lymphoma 16
Attivazione di una immunità specifica per PRAME mediante l'utilizzo di una libreria peptidica in pazienti affetti da patologie ematologiche 16
The dynamics of ABL mutations onset in Ph+ Acute Lymphoblastic Leukemia treated with Imatinib Mesylate 16
Characterization of proteins involved in the mechanism of resistance to Imatinib Mesylate in Chronic Myeloid Leukemia 16
Unravelling the Mechanism of Resistance to Imatinib Mesylate in Chronic Myeloid Leukemia: a Proteomic Approach 16
Clinical relevance in Chronic Myeloid Leukemia of deletion and insertion events in tyrosine kynase domain of BCR-ABL 16
A particular mutational status in a Chronic Myeloid Leukemia patient treated with different tyrosine-Kinase inhibitors 16
Reduced levels of SHP1 provides an additive survival advantage to the Ph+ cells of CML patients and may account for resistance to Ima treatment 16
Deletion and insertion events in tyrosine Kinase domain of BCR-ABL is a common phenomenon in Chronic Myeloid Leukemia 16
Reduced Expression Level of SHP1 Gives An Additive Survival Advantage to the Ph+ Cells of Chronic Myeloid Leukemia (CML) Patients and Provides a Novel Pre-treatment Predictor of Major Molecular Response Achievement in CML Patients 16
Biochimica ematologica in Biochimica del plasma e sistema ematopoietico 15
L'ATTIVITÀ DEGLI INIBITORI DI TIROSINA KINASI (TKI) SULLA PROLIFERAZIONE E L'ATTIVAZIONE DELLE CELLULE T 15
Use of nodulation pattern, stress tolerance, nodC gene amplification, RAPD-PCR and RFLP-16S rDNA analysis to discriminate genotypes of Rhizobium leguminosarum biovar viciae 15
First case of KIT Ser715del and Jak2 Val617Val mutation in systemic mastocytosis with associated essential thrombocythemia 15
Decreased level of SHP-1 provides an additive survival advantage to Philadelphia Chromosome-positive (Ph+) cells derived from patients with Chronic Myeloid Leukemia (CML) and account for resistance to Imatinib (Ima) treatment 15
Frequenza delle mutazioni c-kit in pazienti affetti da Leucemia mieloide acuta (LAM) caratterizzata da alterazioni del gene del core binding factor (CBF) 15
Immunoglobulin heavy and light chains and T-cell receptor beta and gamma chains PCR assessment on cytological samples. A study comparing FTA cards and cryopreserved lymph node fine-needle cytology 15
Cytopathology diagnosis of the thyroidal nodule: a review 15
Flow cytometric immunophenotypic and molecular profiles and follow-up in a case of gamma-delta hepatosplenic T-cell Lymphoma 15
Cytologic, flow cytometry, and molecular assessment of lymphoid infiltrate in fine-needle cytology samples of Hashimoto thyroiditis 14
Frequencies of cKIT mutations detected in patients with Acute Myeloid Leukemia (AML) characterized by Core Binding Factor (CBF) rearrangements 14
First case of S716del mutation in the cKIT gene and V617V mutation in Jak2 gene in a patient affected by essential thrombocytopenia associated to systemic mastocytosis 14
Increasing BCR-.ABL expression levels and/or occurrence of ABL point mutations not always predict resistance to Imatinib Mesylate in BCR-ABL positive Acute Lymphoblastic Leukemia 14
Decrease level of SHP1 provides an additive survival advantage to Philadelphia chromosome-positive (Ph+) cells derived from patients with chronic myeloid leukemia (CML) and account for resistance to Imatinib (Ima) treatment 14
Immunohistochemical algorithms and gene expression profiling in primary cutaneous B-cell lymphoma 14
Characterization of proteins involved in the mechanism of resistance to Imatinib Mesylate in Chronic Myeloid Leukemia 14
Diversity of Rhizobium leguminosa rum biovar viciae strains nodulating wild and crop legumes in central-southern Italy 14
The Expression of shp-1 and SHP-2: A Novel Powerful Predictor of Major Molecular Response (MMR) Achievement in Chronic Myeloid Leukemia Gleevec-Treated Patients Enrolled into the TOPS Clinical Trial 14
Effectiveness of interferon alpha therapy in essential thrombocythemia 14
The expression of shp-1 andSHP-2: A Novel Powerful Predictor of Major Molecular Response (MMR) Achievement in Chronic Myeloid Leukemia Gleevec-Treated Patients Enrolled into the TOPS Clinical Trial 14
The constitutive activated V617F Janus Kinase 2 (JAK2) induces centrosome abnormalities 14
The activity of tyrosine Kinase inhibitors on T-cell proliferation and activation 14
Peritumoral Immune Infiltrate as a Prognostic Biomarker in Thin Melanoma 14
The dynamics of ABL mutations onset in PH+ Acute Lymphoblastic Leukemia treated with Imatinib Mesylate 13
Primo caso di trombocitemia essenziale (TE) associate a mastocitosi ossea con mutazione S715del del gene c-KIT e V616V del gene JAK2 13
UNA BASSA ESPRESSIONE DELLA FOSFATASI SHP-1 CORRELA CON LA RESI-STENZA AL TRATTAMENTO CON INIBITORI DELLE TIROSIN KINASI IN PAZIENTIAFFETTI DA LEUCEMIA MIELOIDE CRONICA 13
Reduced Expression Level of SHP1 Gives An Additive Survival Advantage to the Ph+ Cells of Chronic Myeloid Leukemia (CML) Patients and Provides a Novel Pretreatment Predictor of Major Molecular Response Achievement in CML Patients 13
Evalution of proteolytic, lipolytic and decarboxylase activity of extremely halophilic bacteria occurring in ripening of salt anchovies 13
Light chains expression of lymphoid infiltrate in fine-needle cytology of Hashimoto's Thyroiditis 13
SHP1 expression accounts for resistance to Imatinib treatment in Philadelphia chromosome-positive cells derived from patients with Chronic Myeloid Leukemia 13
La proteina SHP-1 è implicata nella resistenza al trattamenti con Imatinib (Ima) in pazienti affetti da leucemia mieloide cronica (LMC) 12
Induction of preferentially expressed antigen of melanoma (PRAME)-specific immunity by PRAME-overlapping pentadecapeptides in patients with hematologic malignancies, including chronic myelogenous leukemia 12
Increasing the BCR-ABL expression levels and/or the occurrence of ABL point mutations does not always predict resistance to Imatinib Mesylate in BCR-ABL positive acute lymphoblastic leukaemia 12
Clinical relevance in chronic myeloid leukemia of deletion and insertion events in the tyrosine Kinase domain of BCR-ABL 12
Induction of preferentially expressed antigen of melanoma (PRAME)-specific immunity by PRAME-overlapping pentadecapeptides in patients with hematologic malignancies. Including chronic myelogenous leukemia 10
La proteina SHP-1 è implicata nella resistenza al trattamenti con Imatinib (Ima) in pazienti affetti da leucemia mieloide cronica (LMC) 9
Totale 974
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.844
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.844
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025329 0 0 0 64 2 4 5 126 14 0 110 4
2025/2026569 62 69 194 90 88 5 2 1 8 27 21 2
2026/202776 11 48 17 0 0 0 0 0 0 0 0 0
Totale 974